Integrated Dry and Wet Lab for Biologics Discovery
Vibrant Therapeutics leverages a multidisciplinary approach, integrating antibody discovery, protein engineering, and computational tools to develop innovative therapeutics. Our research focuses on potentially life-saving biotherapeutics for patients with critical illness.
We unlock the secrets of proteins to design new biotherapeutics with targeted functions and improved qualities.
Vibrant BumbleBee platform combines advanced computing and multi-specific antibody engineering to streamline the discovery process. This one-stop solution helps us create safer, more effective, and higher-quality biotherapeutics.
Vibrant LogicBee platform uses cutting-edge proteomics analysis to identify key proteins that differ between healthy and diseased tissues. This paves the way for designing biotherapeutics that precisely target diseases.
If you have any R&D challenge of complex biotherapeutics, we would like to hear from you!
Please contact us at BD@vibrantx.io.
Acknowledging the challenges in elucidating the relationships between protein sequences, 3D structures, and therapeutic functions, Vibrant Therapeutics has significantly advanced our understanding of these relationships. This paves the way for the design of revolutionary biotherapeutics to address unmet medical needs.
Vibrant drug discovery platform goes beyond early-stage biomolecule design. It also considers late-stage druggability and manufacturability, ensuring efficient development throughout the entire process.
The structures of novel and complex biomolecules can now be predicted efficiently with much improved accuracy. This technology allows us to create an immense virtual library of antibody mutants, containing countless structures that can be scaled infinitely.
Vibrant Therapeutics seeks passionate business and scientific leaders to join our team in the US or China. We offer the opportunity to create a positive impact on patients' lives.